戻る Agenda
International Collaboration in Times of Public Health Crisis
Session Chair(s)
Ian Hudson
Senior Advisor, Integrated Development
Bill and Melinda Gates Foundation, United States
International collaboration amongst regulators is important from the industry aspiration that it should suffice to develop one global dossier. In the wake of the Ebola crisis, and again during the current Zika event, regulators have and are demonstrating a willingness to find new and pragmatic ways of working together with industry with the ultimate goal of providing health care solutions which are in demand by society. Are there lessons learned that can be shared and discussed? Can the envelope be pushed even further?
Learning Objective : Describe the current state of cooperation amongst regulators during Public Health Emergencies; Identify the challenges faced by the stakeholders, Discuss lessons learned in addressing the challenges.
Speaker(s)
Crisis Management in the Face of a Global Health Pandemic: How Can We Leverage International Efforts?
Jarbas Barbosa da Silva, MD, PHD
Pan American Health Organization, United States
Assistant Director
Update From the FDA
Carmen T. Maher, BSN, MA, RN, RAC
FDA, United States
Acting Assistant Commissioner for Counterterrorism Policy, OCS, OC
Update from the EMA
Agnès Saint-Raymond, DrMed
European Medicines Agency, Netherlands
Head of Division International Affairs